EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 3.0

Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients – a systematic review and meta-analysis

Michal Matuszewski, Jerzy Ładny, Zubaid Rafique, Frank Peacock, Michal Pruc, Aleksandra Gasecka, Piotr Szwed, Lukasz Jankowski, Jaroslaw Chmielewski, Lech Panasiuk, Lukasz Szarpak

Annals of Agricultural and Environmental Medicine · 2023

DOI: 10.26444/aaem/160084 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Annals of Agricultural and Environmental Medicine, 2023. Verfasst von Michal Matuszewski und 10 weiteren Autor:innen. Beteiligte Einrichtung: Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland. Hauptthemen laut MEDLINE: Receptors, Urokinase Plasminogen Activator, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVE: In COVID-19, the rapid prediction of the severity of a patient's condition using modern biomarkers can accelerate the implementation of appropriate therapy, and thus improve the patient's prognosis. MATERIAL AND METHODS: A meta-analysis was conducted of data available in the literature on the differences in baseline suPAR blood concentration between patients (1) who tested positive and negative for COVID-19, (2) who had severe and non-severe COVID-19, and (3) COVID-19 survivors and non-survivors. RESULTS: SuPAR levels in SARS-CoV-2 negative and positive patients varied and amounted to 3.61±1.59 ng/ml vs. 6.45±3.13 ng/ml, respectively (MD = -3.18; 95%CI: -4.71 to -1.66; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Urokinase Plasminogen ActivatorCOVID-19HumansSARS-CoV-2Disease ProgressionBiomarkers

Stichwörter der Autor:innen

COVID-19SARS-CoV-2markermeta-analysispredictorsoluble urokinase plasminogen activator receptorsuPAR

Substanzen

Receptors, Urokinase Plasminogen ActivatorBiomarkers

Autor:innen und Institutionen

  • Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland.
  • Polish Society of Disaster Medicine, Poland.
  • Medical University, Bialystok, Poland.
  • Baylor College of Medicine, Houston, United States.
  • Medical University, Warsaw, Poland.
  • The Institute of Environmental Protection - National Research Institute (IEP-NRI), Warsaw, Poland.

Zitieren

APA

Matuszewski, M., Ładny, J., Rafique, Z., Peacock, F., Pruc, M., Gasecka, A., Szwed, P., Jankowski, L., Chmielewski, J., Panasiuk, L., & Szarpak, L. (2023). Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients – a systematic review and meta-analysis. Annals of Agricultural and Environmental Medicine. https://doi.org/10.26444/aaem/160084

Vancouver

Matuszewski M, Ładny J, Rafique Z, Peacock F, Pruc M, Gasecka A, et al. Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients – a systematic review and meta-analysis. Annals of Agricultural and Environmental Medicine. 2023. doi:10.26444/aaem/160084

BibTeX
@article{Matuszewski2023,
  author = {Matuszewski, Michal and Ładny, Jerzy and Rafique, Zubaid and Peacock, Frank and Pruc, Michal and Gasecka, Aleksandra and Szwed, Piotr and Jankowski, Lukasz and Chmielewski, Jaroslaw and Panasiuk, Lech and Szarpak, Lukasz},
  title = {Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients – a systematic review and meta-analysis},
  journal = {Annals of Agricultural and Environmental Medicine},
  year = {2023},
  doi = {10.26444/aaem/160084}
}
Kostenlos starten →